Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
CEP164 has been recently associated with a motile ciliopathy phenotype in a patient presenting with bronchiectasis, infertility, and hydrocephalus who harboured compound heterozygous loss-of-function variants in CEP164. The autosomal recessive inheritance is supported by two truncating changes (c.4228C>T (p.Arg576Ter)) (PMID:36273371) lacking segregation data but consistent with a loss-of-function mechanism in primary ciliogenesis.
Functional assays demonstrate that CEP164 binding to TTBK2 is essential for CP110 removal and ciliogenesis in human cells, with loss of interaction impairing ciliary assembly and mirroring patient phenotypes (PMID:25297623). This evidence supports CEP164 haploinsufficiency as the likely pathogenic mechanism in both primary and motile ciliopathy syndromes. CEP164 should be included in genetic testing panels for suspected ciliopathy patients.
Gene–Disease AssociationLimitedOne proband with compound heterozygous loss-of-function CEP164 variants (AR inheritance), no segregation data, preliminary functional concordance Genetic EvidenceLimitedOne reported proband with biallelic predicted loss-of-function variants: c.4228C>T (p.Arg576Ter) ([PMID:36273371]) under autosomal recessive inheritance Functional EvidenceModerateCellular assays demonstrate CEP164 binding to TTBK2 is essential for ciliogenesis; loss-of-function consistent with patient phenotype ([PMID:25297623]) |